MDM2 and embryonal rhabdomyosarcoma: Additionally, we have shown that MDM2-ALT1 is expressed in over 85% alveolar and 70% embryonal rhabdomyosarcoma (RMS) tumors and that its expression is correlated with high-grade metastatic disease, irrespective of histological subtype (5).